Date: May 1, 2007
Summary:
Scientists believe the rapid mutation of a gene in chronic myeloid leukemia stem cells may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute. The original news release can be found
